SCHEDULE 14A (RULE 14A-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant / / Filed by a Party other than the Registrant /X/ Check the appropriate box: / / Preliminary Proxy Statement / / Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) / / Definitive Proxy Statement /X/ Definitive Additional Materials / / Soliciting Material Under Rule 14a-12 LIFEPOINT HOSPITALS, INC. - -------------------------------------------------------------------------------- (Name of Registrant as Specified in Its Charter) ACCIPITER LIFE SCIENCES FUND, LP ACCIPITER LIFE SCIENCES FUND II, LP ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD. ACCIPITER LIFE SCIENCES FUND II (OFFSHORE), LTD. ACCIPITER LIFE SCIENCES FUND II (QP), LP ACCIPITER CAPITAL MANAGEMENT, LLC CANDENS CAPITAL, LLC GABE HOFFMAN MOHSIN Y. MEGHJI EARL P. HOLLAND NICOLE VIGLUCCI - -------------------------------------------------------------------------------- (Name of Persons(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): /X/ No fee required. / / Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.(1) Title of each class of securities to which transaction applies: - -------------------------------------------------------------------------------- (2) Aggregate number of securities to which transaction applies: - -------------------------------------------------------------------------------- (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): - -------------------------------------------------------------------------------- (4) Proposed maximum aggregate value of transaction: - -------------------------------------------------------------------------------- (5) Total fee paid: - -------------------------------------------------------------------------------- / / Fee paid previously with preliminary materials: - -------------------------------------------------------------------------------- / / Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. (1) Amount previously paid: - -------------------------------------------------------------------------------- (2) Form, Schedule or Registration Statement No.: - -------------------------------------------------------------------------------- (3) Filing Party: - -------------------------------------------------------------------------------- (4) Date Filed: -2- On April 20, 2006, Accipiter Life Sciences Fund, LP ("Accipiter"), together with the other participants, made a definitive filing with the Securities and Exchange Commission of a proxy statement (the "Statement") and an accompanying proxy card to be used to solicit votes for the election of its nominees at the 2006 annual meeting of stockholders (the "Annual Meeting") of LifePoint Hospitals, Inc., a Delaware corporation (the "Company"). On April 25, 2006, the Delaware Chancery Court decided not to grant Accipiter's motion for preliminary judgment in connection with the Annual Meeting. Accipiter and the other participants have decided not to use the Statement for the purpose of soliciting proxies for the election of Accipiter's nominees at the Annual Meeting. Accipiter will not vote any shares represented by GOLD proxy cards at the Annual Meeting.
- Company Dashboard
- Filings
- Holdings
-
DFAN14A Filing
Accipiter Capital Management DFAN14AAdditional proxy materials by non-management
Filed: 3 May 06, 12:00am